$170.00
Premium (LY3437943) for laboratory research. This advanced triple agonist peptide targets GIP, GLP-1, and glucagon receptors for comprehensive metabolic research.
(LY3437943) is a synthetic, long-acting triagonist peptide that simultaneously activates the glucose‑dependent insulinotropic polypeptide receptor (GIPR), glucagon‑like peptide‑1 receptor (GLP‑1R), and glucagon receptor (GCGR).
(LY3437943) is a synthetic, long-acting triagonist peptide that simultaneously activates the glucose‑dependent insulinotropic polypeptide receptor (GIPR), glucagon‑like peptide‑1 receptor (GLP‑1R), and glucagon receptor (GCGR).
